HIV's achilles' heel

Scientific American

Volumn 315, Issue 6, 2016, Pages 50-55

  Sanders, Rogier W ^a,b   Wilson, Ian A ^c   Moore, John P ^d  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d Department of Microbiology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS ANTIBODY;

BIOSYNTHESIS; HIV INFECTIONS; HUMAN; IMMUNOLOGY;

AIDS VACCINES; ANTIBODIES, VIRAL; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HUMANS;

EID: 85016174197     PISSN: 00368733     EISSN: None     Source Type: Journal    
DOI: 10.1038/scientificamerican1216-50     Document Type: Article

References (2)

1. A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies. Rogier W. Sanders et al. in PLOS Pathogens, Vol. 9, No. 9, Article No. e1003618; September 19, 2013. www.ncbi.nlm.nih.gov/pmc/articles/PMC3777863
2. An HIV Vaccine: Mapping Uncharted Territory. Anthony S. Fauci in Journal of the American Medical Association, Vol. 316, No. 2, pages 143-144; July 12, 2016. HIV vaccine research described at the National Institute of Allergy and Infectious Diseases: www.niaid.nih.gov/topics/hivaids/research/vaccines